Patient-reported influences on COVID-19 vaccine acceptance and hesitancy in people with hidradenitis suppurativa.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 37210215.
- Also identified by DOI 10.1093/bjd/ljad166 and PMC identifier 10449532.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
COVID-19 continues to pose a risk to patients with hidradenitis suppurativa (HS) due to the high prevalence of comorbidities associated with severe COVID-19 disease. We aimed to characterize perspectives on COVID-19 vaccination among patients with HS. International respondents from 20 online HS support groups were recruited to complete a voluntary, anonymous, online cross-sectional survey from 25 October to 21 November 2021 to obtain perspectives from people with HS who may and may not access healthcare. We report higher rates of COVID-19 vaccine hesitancy among patients with HS who expressed dissatisfaction with their dermatological care.
Medical subject headings
- Hidradenitis Suppurativa
- COVID-19